Post-Acute COVID-19 Vaccination Syndrome (PACVS)

A new systematic review of 20 studies documents COVID-19 vaccine mRNA, spike protein, and lipid nanoparticles persisting in blood and tissues for months to years. The authors call for urgent investigation.

A new IMA paper in Frontiers in Medicine charts a path for diagnosing Post-Acute COVID-19 Vaccination Syndrome, or PACVS, by proposing biomarkers, protocols, and a practical clinical framework.

Standard tests miss it. Doctors can't explain it. New research points to mitochondrial dysfunction as a central driver of both long COVID and PACVS—and a path toward targeted treatment.

Fatigue after COVID vaccination is real, measurable, and increasingly understood. This new review by IMA researchers highlights the biological mechanisms that may explain why.

For the first time, a mainstream, high-impact medical journal has published a comprehensive investigation into this emerging post-vaccination condition.

A growing body of research identifies autoimmune mechanisms behind persistent COVID vaccine side effects, revealing antibody patterns that may explain PACVS symptoms.

'Breaking the Silence: Recognizing Post-Vaccination Syndrome,' a new peer-reviewed study co-authored by IMA President and Chief Medical Officer Dr. Joseph Varon and Director of Scientific Research Matthew Halma, was recently published in the Heliyon Journal. The study found clear evidence that Post-Acute COVID-19 Vaccination Syndrome (PACVS) is a distinct and measurable medical condition.